About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The search for quality and innovation has always been an inherent part of the activity of the Stroke Research Group and represents the common thread that leads us to excellence and continuous improvement.
In recent years, the Stroke Research Group has established itself as a leader in the management, recruitment and international coordination of multicenter clinical trials, as well as in the development of patents for new thrombectomy devices and the creation of new technological solutions and digital platforms to improve the diagnosis, treatment and follow-up of stroke patients. Robust strategic alliances have also been consolidated with public and private entities that ensure the viability and scalability of the research projects initiated in our group.
The Stroke Research Group is made up of a transversal and multidisciplinary team that shares a common idea: to contribute from its area of knowledge to the care and management of stroke through the effective transfer of knowledge and the complementarity of the processes of clinical research.
Responsible: Dr. David Rodríguez Luna
IP: -
Responsible: Dr. Jorge Pagola
Responsible: Dr. Carlos Molina
IP: Jorge Pagola Pérez Blanca Collaborators: José Alvarez Sabin, Noelia Rodríguez Villatoro, Jaume Francisco Pascual, Hug Cuellar Calabria, ESCALA DE RIESGO DE ICTUS EN PACIENTES CON FIBRILACIÓN AURICULAR Y ANTICOAGULANTES ORALES DIRECTOS, Claudia Meza Burgos, Federica Rizzo Funding agency: Instituto de Salud Carlos III Funding: 61250 Reference: PI24/00333 Duration: 01/01/2025 - 31/12/2027
IP: Carlos Molina Cateriano Collaborators: Ester Sanchez Gavilan, Olalla Pancorbo Rosal, Claudia Meza Burgos, Carole Conforti, Giulio Maria Fiore Funding agency: EUROPEAN COMMISSION Funding: 1131945 Reference: EASTSTROKE_HE-HLTH-2024 Duration: 01/12/2024 - 30/11/2030
IP: Marc Ribó Jacobi Collaborators: - Funding agency: Fundació "La Caixa" Funding: 395016 Reference: HR24-00927 Duration: 01/11/2024 - 31/10/2027
IP: Carlos Molina Cateriano Collaborators: Estela Sanjuan Menendez, Laura Rivera Sanchez, Carolina Paredes Deiros, Olalla Pancorbo Rosal, Gabriela Isabel Fuentes Llopis, David Rodriguez Luna, Mª Ángeles Muchada López, Giorgio Colangelo , Renato Simonetti , Nicoletta Brunelli Funding agency: EUROPEAN COMMISSION Funding: 1856250 Reference: UMBRELLA_MOLINA_IHI2024 Duration: 01/10/2024 - 30/09/2029
The funding will enable the company, emerged from the Vall d'Hebron ecosystem, to complete the clinical development of its technology and move closer to making it available to patients.
The RECUPERA project, led by DyCare and Ephion Health in collaboration with Vall d’Hebron, Eurecat, and the Ictus Foundation, will combine AI, computer vision, and biomechanical sensors to measure patient progress and tailor exercises to their needs.
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
